T
Tomohiko Ichikawa
Researcher at Chiba University
Publications - 377
Citations - 9575
Tomohiko Ichikawa is an academic researcher from Chiba University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 48, co-authored 348 publications receiving 8583 citations. Previous affiliations of Tomohiko Ichikawa include Teikyo University & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.
Jin-Tang Dong,Patricia W. Lamb,Carrie W. Rinker-Schaeffer,Jasminka Vukanovic,Tomohiko Ichikawa,John T. Isaacs,J C Barrett +6 more
TL;DR: A gene from human chromosome 11p11.2 was isolated and was shown to suppress metastasis when introduced into rat AT6.1 prostate cancer cells.
Journal ArticleDOI
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase ( PNP ) in prostate cancer
Satoko Kojima,Takeshi Chiyomaru,Kazumori Kawakami,Hirofumi Yoshino,Hideki Enokida,Nijiro Nohata,Miki Fuse,Tomohiko Ichikawa,Yukio Naya,Masayuki Nakagawa,Naohiko Seki +10 more
TL;DR: The PNP is a novel target gene of both miRNAs and potentially functions as an oncogene and may provide new insights into the underlying causes of PCa oncogenesis, which is a frequent event in PCa and both function as tumour suppressors.
Journal Article
Decreased Expression of E-Cadherin in the Progression of Rat Prostatic Cancer
Marion J.G. Bussemakers,Reindert J.A. Van Moorselaar,Laurence A. Giroldi,Tomohiko Ichikawa,John T. Isaacs,Masatoshi Takeichi,Frans M.J. Debruyne,Jack A. Schalken +7 more
TL;DR: Results suggest that a decreased expression of E-cadherin is associated with the progression of prostatic cancer.
Journal ArticleDOI
Androgen receptor involvement in the progression of prostate cancer.
TL;DR: Genetic diagnosis and/or molecular-targeted therapy via AR pathways can be developed for hormone-refractory states and several co-factors between ARs and the transcriptional complex have been cloned and reports indicate that steroid receptor co-activator 1 is correlated with the hormone- Refractory progression of prostate cancer.
Journal ArticleDOI
Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1
Miki Fuse,Nijiro Nohata,Satoko Kojima,Shinichi Sakamoto,Takeshi Chiyomaru,Kazumori Kawakami,Hideki Enokida,Masayuki Nakagawa,Yukio Naya,Tomohiko Ichikawa,Naohiko Seki +10 more
TL;DR: Using the PC cell lines, gain-of-function assays revealed that miR-145 transfection inhibited cell proliferation, migration and invasion, implying that FSCN1 is associated with the progression of PC.